Page last updated: 2024-11-05

zolpidem and Anti-N-Methyl-D-Aspartate Receptor Encephalitis

zolpidem has been researched along with Anti-N-Methyl-D-Aspartate Receptor Encephalitis in 2 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.

Research Excerpts

ExcerptRelevanceReference
"Zolpidem would be a reasonable consideration as an adjunctive treatment in anti-N-methyl-d-aspartate receptor encephalitis after tumor removal and immunotherapy to accelerate recovery and rehabilitation."7.80Clinically significant response to zolpidem in disorders of consciousness secondary to anti-N-methyl-D-aspartate receptor encephalitis in a teenager: a case report. ( Appu, M; Noetzel, M, 2014)
"Zolpidem would be a reasonable consideration as an adjunctive treatment in anti-N-methyl-d-aspartate receptor encephalitis after tumor removal and immunotherapy to accelerate recovery and rehabilitation."3.80Clinically significant response to zolpidem in disorders of consciousness secondary to anti-N-methyl-D-aspartate receptor encephalitis in a teenager: a case report. ( Appu, M; Noetzel, M, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Spiegel, DR1
Ahuja, K1
Reid, FE1
Hegde, S1
Carbaugh, E1
Tran, V1
Forte, S1
Strauss, E1
Lagbo, J1
Lau, J1
Appu, M1
Noetzel, M1

Other Studies

2 other studies available for zolpidem and Anti-N-Methyl-D-Aspartate Receptor Encephalitis

ArticleYear
A Case of Ovarian Teratoma-Induced N-Methyl-D-Aspartate Receptor Antibody Encephalitis Presenting With Psychosis and Catatonia, Progressing to the Minimally Conscious State and Successfully Treated With Adjunctive Zolpidem.
    The primary care companion for CNS disorders, 2023, 08-01, Volume: 25, Issue:4

    Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies; Catatonia; Encephalitis; Female; Hu

2023
Clinically significant response to zolpidem in disorders of consciousness secondary to anti-N-methyl-D-aspartate receptor encephalitis in a teenager: a case report.
    Pediatric neurology, 2014, Volume: 50, Issue:3

    Topics: Adolescent; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Central Nervous System Agents; Consciou

2014